AU Patent

AU2018304373A1 — Compositions comprising darunavir, cobicistat, emtricitabine and tenofovir alafenamide for use in the treatment of HIV

Assigned to Janssen Sciences Ireland ULC · Expires 2020-01-30 · 6y expired

What this patent protects

Patent listed against Tybost.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018304373A1
Jurisdiction
AU
Classification
—
Expires
2020-01-30
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Sciences Ireland ULC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.